[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:biliary-tract-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":98,"states":99},"Biliary Tract Carcinoma",14,12,[8,16,22,29,35,41,47,54,60,66,72,78,84,91],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05849480","A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:30.145302Z","2026-05-05T02:43:28.618842Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05482893","Spevatamig (PT886) as Monotherapy or in Combination With Chemo and\u002For ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)",[12],"2026-08-26T02:16:36.513735Z","2026-07-19T19:36:05.117317Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07277413","A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",[26],"Phase 1","2026-08-26T02:16:01.910993Z","2026-07-05T05:32:16.679197Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07594626","BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion",[12],"2026-08-26T02:17:39.048487Z","2026-05-29T15:36:40.204907Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05123482","A Phase I\u002FIIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced\u002FMetastatic Solid Malignancies",[12],"2026-08-26T02:16:02.918558Z","2026-05-05T02:43:28.560845Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06270706","A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors",[26],"2026-08-26T02:18:44.395098Z","2026-05-05T02:43:28.480860Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT07405086","Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study",[51],"Phase 2","2026-08-26T02:17:56.243868Z","2026-05-05T02:43:28.001347Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07016971","CBG\u002FCBD Oil for Chemotherapy-Induced Peripheral Neuropathy",[26],"2026-08-26T02:18:39.640967Z","2026-05-05T02:43:27.436153Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT05969860","At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer",[51],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:26.978986Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05733000","CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors",[51],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:26.767445Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT07285044","The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas",[51],"2026-08-26T02:16:24.135291Z","2026-07-05T05:32:16.672723Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05705492","Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer",[51],"2026-08-26T02:17:05.172421Z","2026-05-05T02:43:27.662523Z",{"nct_id":85,"title":86,"phases":87,"status":88,"updated_at":89,"content_modified":90},"NCT07723534","Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers",[51],"NOT_YET_RECRUITING","2026-08-26T02:16:22.235886Z","2026-07-30T01:46:14.436752Z",{"nct_id":92,"title":93,"phases":94,"status":95,"updated_at":96,"content_modified":97},"NCT06048133","Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)",[51],"ACTIVE_NOT_RECRUITING","2026-08-03T03:16:32.738962Z","2026-05-05T02:43:26.672972Z",[],[100,104,107,111,114,117,120,123],{"state":101,"count":102,"slug":103},"Pennsylvania",4,"pennsylvania",{"state":105,"count":102,"slug":106},"Texas","texas",{"state":108,"count":109,"slug":110},"California",3,"california",{"state":112,"count":109,"slug":113},"Florida","florida",{"state":115,"count":109,"slug":116},"New Jersey","new-jersey",{"state":118,"count":109,"slug":119},"New York","new-york",{"state":121,"count":109,"slug":122},"North Carolina","north-carolina",{"state":124,"count":109,"slug":125},"Virginia","virginia"]